Argent Biopharma Ltd (RGT) — Cash Flow Reinvestment Rate
Latest as of June 2006:
0.00x
Argent Biopharma Ltd (RGT) has a Cash Flow Reinvestment Rate of 0.00x as of June 2006, reinvesting AU$0.00 (capex AU$0.00 ) from operating cash flow of AU$61.70K. See net asset quality index of Argent Biopharma Ltd to measure how much of total assets are equity-financed.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
AU$0.00
Capex + Investments
Operating Cash Flow
AU$61.70K
AUD
Capital Expenditures
AU$0.00
AUD
Argent Biopharma Ltd Cash Flow Reinvestment Rate (2006–2006)
Historical reinvestment intensity for Argent Biopharma Ltd across 1 annual periods. Also explore RGT total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Argent Biopharma Ltd (2006–2006)
Year-by-year capital reinvestment analysis for Argent Biopharma Ltd. For live market cap and broader valuation context, see RGT market cap.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2006 | 0.00x | AU$0.00 | AU$41.00K | AU$0.00 | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow